Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Sitemap: https://www.renexxion.com/sitemap.xml User-agent: NerdyBot Disallow: / User-agent: * Disallow: /ajax/ Disallow: |
Title | RENEXXION - |
Description | Company Company Overview Renexxion LLC is a US based biotechnology company with a wholly owned Irish subsidiary; Renexxion Ireland Limited. We are committed to |
Keywords | N/A |
WebSite | renexxion.com |
Host IP | 209.17.116.163 |
Location | United States |
Site | Rank |
US$1,470
Last updated: 2023-05-08 01:55:29
renexxion.com has Semrush global rank of 0. renexxion.com has an estimated worth of US$ 1,470, based on its estimated Ads revenue. renexxion.com receives approximately 169 unique visitors each day. Its web server is located in United States, with IP address 209.17.116.163. According to SiteAdvisor, renexxion.com is safe to visit. |
Purchase/Sale Value | US$1,470 |
Daily Ads Revenue | US$1 |
Monthly Ads Revenue | US$40 |
Yearly Ads Revenue | US$488 |
Daily Unique Visitors | 11 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
renexxion.com. | A | 7198 | IP: 209.17.116.163 |
renexxion.com. | NS | 14400 | NS Record: dns102.register.com. |
renexxion.com. | NS | 14400 | NS Record: dns101.register.com. |
renexxion.com. | MX | 7200 | MX Record: 0 renexxion-com.mail.protection.outlook.com. |
renexxion.com. | TXT | 3600 | TXT Record: MS=ms81521292 |
renexxion.com. | TXT | 14400 | TXT Record: v=spf1 include:spf.protection.outlook.com include:_spf.google.com -all |
Company Overview Renexxion LLC is a US based biotechnology company with a wholly owned Irish subsidiary; Renexxion Ireland Limited. We are committed to delivering innovative drugs to patients with a high unmet need in gastrointestinal disorders with its pipeline in a pill: Naronapride. For more information on Naronapride visit: https://www.rnexltd.ie/ Founders Our leadership team is composed of biotech industry veterans with many years of experience in all areas of pharmaceutical drug development, management and financing. Peter G. Milner MD, FACC Co-Founder and Director MORE Pascal Druzgala PhD Co-Founder and Director MORE Ken Kengatharan PhD, MBA Co-Founder and Director MORE Naronapride: Pipeline in a Pill Learn about Renexxion’s innovation with Naronapride. Learn about Naronapride Knowledge Center Learn more about gastrointestinal (GI) conditions. Knowledge Center Partnerships Innovation with our strategic partners. Dr. Falk Pharma Get in touch with us. * Indicates |
HTTP/1.1 301 Moved Permanently Server: openresty/1.17.8.2 Date: Fri, 29 Oct 2021 03:29:05 GMT Content-Type: text/html Content-Length: 175 Connection: keep-alive Location: https://www.rnexltd.ie/ HTTP/1.1 200 OK Date: Fri, 29 Oct 2021 03:29:06 GMT Server: Apache Set-Cookie: is_mobile=0; path=/; domain=www.rnexltd.ie Vary: X-W-SSL,Accept-Encoding,User-Agent Set-Cookie: language=en; expires=Fri, 12-Nov-2021 03:29:06 GMT; Max-Age=1209600; path=/ Cache-Control: private ETag: W/"39d58b514d0ab49ed56b5f7f1a0e59cc" X-Host: pages14.sf2p.intern.weebly.net X-UA-Compatible: IE=edge,chrome=1 Content-Type: text/html; charset=UTF-8 |
Domain Name: RENEXXION.COM Registry Domain ID: 1970244320_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.register.com Registrar URL: http://www.register.com Updated Date: 2020-03-13T05:30:58Z Creation Date: 2015-10-20T15:28:26Z Registry Expiry Date: 2021-10-20T15:28:26Z Registrar: Register.com, Inc. Registrar IANA ID: 9 Registrar Abuse Contact Email: abuse@web.com Registrar Abuse Contact Phone: +1.8003337680 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: DNS101.REGISTER.COM Name Server: DNS102.REGISTER.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-16T18:04:11Z <<< |